We are live on ! Find out more
AXNX

Axonics, Inc. Common Stock

Delisted

AXNX was delisted on the 14th of November, 2024.

235 hedge funds and large institutions have $3.26B invested in Axonics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 82 funds opening new positions, 41 increasing their positions, 87 reducing their positions, and 74 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more funds holding in top 10

Funds holding in top 10: 418 (+14)

11% more first-time investments, than exits

New positions opened: 82 | Existing positions closed: 74

2% more funds holding

Funds holding: 230235 (+5)

2% more capital invested

Capital invested by funds: $3.19B → $3.26B (+$73M)

20% less call options, than puts

Call options by funds: $17.3M | Put options by funds: $21.6M

53% less repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 87

Holders
235
Holders Change
+5
Holders Change %
+2.17%
% of All Funds
3.39%
Holding in Top 10
18
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+350%
% of All Funds
0.26%
New
82
Increased
41
Reduced
87
Closed
74
Calls
$17.3M
Puts
$21.6M
Net Calls
-$4.25M
Net Calls Change
-$9.34M

AXNX Hedge Fund Activity: Q1 2024 in Review

235 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q1 2024, worth a combined $3.26B — up 2.3% from $3.19B a quarter earlier.

Buyers outnumbered sellers: 82 funds opened new AXNX positions and 74 closed out — a net gain of 8 holders — while 41 added to existing stakes and 87 trimmed.

The largest buyer was UBS O'Connor, adding an estimated $128M. The largest seller was Fidelity Investments, cutting an estimated $337M.

  • 235 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q1 2024, up from 230 in Q4 2023.
  • Funds reported $3.26B of Axonics, Inc. Common Stock stock for Q1 2024, up 2.3% quarter-over-quarter.
  • 82 funds opened new Axonics, Inc. Common Stock positions in Q1 2024 and 74 closed out, a net change of +8 holders.
  • The largest Axonics, Inc. Common Stock buyer in Q1 2024 was UBS O'Connor, an estimated $128M added.
  • The largest Axonics, Inc. Common Stock seller in Q1 2024 was Fidelity Investments, an estimated $337M sold.

Based on aggregated 13F filings for Q1 2024.